Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 6/2018

01-06-2018 | Review

Lessons learned from splenic infarcts with fever of unknown origin (FUO): culture-negative endocarditis (CNE) or malignancy?

Authors: Burke A. Cunha, Bertamaria Dieguez, Alena Varantsova

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 6/2018

Login to get access

Abstract

Culture negative endocarditis (CNE) is a common concern in patients with fever, heart murmur, cardiac vegetation, and negative blood cultures. The diagnosis of CNE is not based only on negative blood cultures and a cardiac vegetation. The clinical definition of CNE is based on negative blood cultures plus the findings of culture positive infective endocarditis (IE), e.g., fever, cardiac vegetation, splenomegaly, peripheral manifestations. Because embolic splenic infarcts may occur with culture positive IE, some may assume that splenic infarcts are a sign of CNE. Previously, CNE was due to fastidious and non-culturable organisms. With current diagnostic methods, fastidious organisms grow in 2–3 days. Therefore, fastidious IE are a subset of culture positive IE, but do not represent true CNE. We describe a case of an elderly female who presented with a fever of unknown origin (FUO) and multiple splenic infarcts thought by some to represent CNE. An extensive workup for CNE pathogens was negative. The final cause of her splenic infarcts was a diffuse large B-cell lymphoma (DLBCL). Review of the literature, as well as this case, confirms that splenic infarcts are not a feature of CNE. In patients with fever, splenic infarcts, and negative blood cultures, physicians should search for an alternate explanation rather than CNE, e.g., malignancy and hypercoaguable state (lupus anticoagulant).
Literature
1.
go back to reference Peterdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1–3CrossRef Peterdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1–3CrossRef
2.
go back to reference Peterdorf RG (1992) Fever of unknown origin: an old friend revisited. Arch Intern Med 152:21–22CrossRef Peterdorf RG (1992) Fever of unknown origin: an old friend revisited. Arch Intern Med 152:21–22CrossRef
3.
go back to reference Murray HW (ed) (1983) FUO: fever of undetermined origin. Futura Publishing, Mount Kisko Murray HW (ed) (1983) FUO: fever of undetermined origin. Futura Publishing, Mount Kisko
4.
go back to reference Cunha BA (ed) (2007) Fever of unknown origin. Informa, New York Cunha BA (ed) (2007) Fever of unknown origin. Informa, New York
6.
go back to reference Cunha BA (2007) Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin N Am 21:1137–1187CrossRef Cunha BA (2007) Fever of unknown origin: focused diagnostic approach based on clinical clues from the history, physical examination, and laboratory tests. Infect Dis Clin N Am 21:1137–1187CrossRef
7.
go back to reference Cunha CB (2017) Diagnositc tests in infectious diseases. In: Cunha CB, Cunha BA (eds) Antibiotic Essentials, 15th edn. JayPee Medical Publishers, New Delhi, pp 1137–1187 Cunha CB (2017) Diagnositc tests in infectious diseases. In: Cunha CB, Cunha BA (eds) Antibiotic Essentials, 15th edn. JayPee Medical Publishers, New Delhi, pp 1137–1187
8.
go back to reference Cunha BA (2004) Fever of unknown origin. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases, 3rd edn. Lippincott Williams & Wilkins, New York, pp 1568–1577 Cunha BA (2004) Fever of unknown origin. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases, 3rd edn. Lippincott Williams & Wilkins, New York, pp 1568–1577
9.
go back to reference Cunha CB, Cunha BA (2015) Fever of unknown origin. In: Schlossberg D (ed) Clinical infectious disease. Cambridge University Press, Cambridge, pp 2–12CrossRef Cunha CB, Cunha BA (2015) Fever of unknown origin. In: Schlossberg D (ed) Clinical infectious disease. Cambridge University Press, Cambridge, pp 2–12CrossRef
10.
go back to reference Cunha BA (2004) Fever in malignant disorders. Infect Dis Pract 26:335–336 Cunha BA (2004) Fever in malignant disorders. Infect Dis Pract 26:335–336
11.
go back to reference Luft FC, Rissing JP, White A, Brooks GF (1976) Infections or neoplasm as causes of prolonged fever in cancer patients. Am J Med Sci 272:65–74CrossRefPubMed Luft FC, Rissing JP, White A, Brooks GF (1976) Infections or neoplasm as causes of prolonged fever in cancer patients. Am J Med Sci 272:65–74CrossRefPubMed
12.
go back to reference Meytes D, Ballin A (1991) Unexplained fever in hematologic disorders: malignant hematologic disorders. In: Isaac B, Kernbaum S, Burke M (eds) Unexplained fever. CRC Press, Boca Raton, pp 209–224 Meytes D, Ballin A (1991) Unexplained fever in hematologic disorders: malignant hematologic disorders. In: Isaac B, Kernbaum S, Burke M (eds) Unexplained fever. CRC Press, Boca Raton, pp 209–224
13.
go back to reference Wang C, Armstrong D (1983) Neoplastic disease. In: Murray HW (ed) FUO: fever of undetermined origin. Futura, Mount Kisko, pp 39–46 Wang C, Armstrong D (1983) Neoplastic disease. In: Murray HW (ed) FUO: fever of undetermined origin. Futura, Mount Kisko, pp 39–46
14.
go back to reference Roca CV, Rodriguez SH (2007) Malignant lymphomas presenting as fever of unknown origin. An Med Interna 24:531–534 Roca CV, Rodriguez SH (2007) Malignant lymphomas presenting as fever of unknown origin. An Med Interna 24:531–534
15.
go back to reference Weinstein L, Brusch JL (eds) (1996) Infective endocarditis. Oxford University Press, New York Weinstein L, Brusch JL (eds) (1996) Infective endocarditis. Oxford University Press, New York
16.
go back to reference McDermott BP, Cunha BA, Choi D, Cohen J, Hage J (2011) Transthoracic echocardiography (TTE): sufficiently sensitive screening test for native vale infection endocarditis (IE). Heart Lung 40:358–360CrossRefPubMed McDermott BP, Cunha BA, Choi D, Cohen J, Hage J (2011) Transthoracic echocardiography (TTE): sufficiently sensitive screening test for native vale infection endocarditis (IE). Heart Lung 40:358–360CrossRefPubMed
17.
go back to reference Rubenson DS, Tucker CR, Stinson EG (1981) The use of echocardiography in diagnosing culture negative endocarditis. Circulation 64:641–646CrossRefPubMed Rubenson DS, Tucker CR, Stinson EG (1981) The use of echocardiography in diagnosing culture negative endocarditis. Circulation 64:641–646CrossRefPubMed
18.
go back to reference Cunha BA (2007) The mimics of endocarditis. In: Brusch J (ed) Infectious endocarditis. Informa, NY, pp 345–353 Cunha BA (2007) The mimics of endocarditis. In: Brusch J (ed) Infectious endocarditis. Informa, NY, pp 345–353
19.
go back to reference Van Scoy RE (1982) Culture negative endocarditis. Mayo Clin Proc 5:149–154 Van Scoy RE (1982) Culture negative endocarditis. Mayo Clin Proc 5:149–154
20.
go back to reference Brusch J (2007) Organisms of blood culture-negative endocarditis. In: Brusch J (ed) Infectious endocarditis. Informa, NY, pp 73–99 Brusch J (2007) Organisms of blood culture-negative endocarditis. In: Brusch J (ed) Infectious endocarditis. Informa, NY, pp 73–99
21.
go back to reference Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C et al (2005) Contribution of systemic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43:5238–5242CrossRefPubMedPubMedCentral Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C et al (2005) Contribution of systemic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43:5238–5242CrossRefPubMedPubMedCentral
22.
go back to reference Houpikian P, Raoult D (2005) Blood culture negative endocarditis in a reference center. Medicine 84:162CrossRefPubMed Houpikian P, Raoult D (2005) Blood culture negative endocarditis in a reference center. Medicine 84:162CrossRefPubMed
24.
go back to reference Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP et al (2010) Comprehensive diagnostic strategy for blood culture negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51:131–140CrossRefPubMed Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP et al (2010) Comprehensive diagnostic strategy for blood culture negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis 51:131–140CrossRefPubMed
25.
go back to reference Pesanti EL, Smith IM (1979) Infective endocarditis with negative blood cultures: an analysis of 52 cases. Am J Med 66:43–50CrossRefPubMed Pesanti EL, Smith IM (1979) Infective endocarditis with negative blood cultures: an analysis of 52 cases. Am J Med 66:43–50CrossRefPubMed
26.
go back to reference Cannaday PB, Sanford JP (1976) Negative blood cultures in infective endocarditis: a review. South Med J 69:1420–1424CrossRef Cannaday PB, Sanford JP (1976) Negative blood cultures in infective endocarditis: a review. South Med J 69:1420–1424CrossRef
28.
go back to reference Brensilver HL, Kaplan MM (1975) Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 68:1556–1562PubMed Brensilver HL, Kaplan MM (1975) Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 68:1556–1562PubMed
29.
go back to reference Cunha BA (2007) Fever of unknown origin (FUO). Diagnostic serum ferritin levels. Scand J Infect Dis 39:651–652CrossRefPubMed Cunha BA (2007) Fever of unknown origin (FUO). Diagnostic serum ferritin levels. Scand J Infect Dis 39:651–652CrossRefPubMed
30.
go back to reference Cunha BA (2004) Diagnostic significance of nonspecific laboratory tests in infectious diseases. In: Bartlett JG, Blacklow NR (eds) Infectious diseases, 3rd edn. Lippincott Williams, Baltimore, pp 158–166 Cunha BA (2004) Diagnostic significance of nonspecific laboratory tests in infectious diseases. In: Bartlett JG, Blacklow NR (eds) Infectious diseases, 3rd edn. Lippincott Williams, Baltimore, pp 158–166
31.
go back to reference Baldridge CW, Awe CD (1938) Lymphoma: a study of one hundred and fifty cases. Arch Intern Med 45:161–190CrossRef Baldridge CW, Awe CD (1938) Lymphoma: a study of one hundred and fifty cases. Arch Intern Med 45:161–190CrossRef
32.
go back to reference Hsi ED, Gascoyne RD, Goldblum RD (2007) Diffuse aggressive B-cell lymphomas. In: His ED, Goldblum RD (eds) Hematopathology. Churchill Livingston, Philadelphia, pp 259–282 Hsi ED, Gascoyne RD, Goldblum RD (2007) Diffuse aggressive B-cell lymphomas. In: His ED, Goldblum RD (eds) Hematopathology. Churchill Livingston, Philadelphia, pp 259–282
33.
go back to reference Jaroch MT, Broughan TA, Hermann RE (1986) The natural history of splenic infarction. Surgery 100:743–750PubMed Jaroch MT, Broughan TA, Hermann RE (1986) The natural history of splenic infarction. Surgery 100:743–750PubMed
34.
go back to reference Goerg C, Schwerk WB (1990) Splenic infarction: sonographic patterns, diagnosis, follow up and complications. Radiology 174:803–807CrossRefPubMed Goerg C, Schwerk WB (1990) Splenic infarction: sonographic patterns, diagnosis, follow up and complications. Radiology 174:803–807CrossRefPubMed
35.
go back to reference Nores M, Phillips EH, Morgenstern L, Hiatt JR (1998) The clinical spectrum of splenic infarction. Am Surg 64:182–188PubMed Nores M, Phillips EH, Morgenstern L, Hiatt JR (1998) The clinical spectrum of splenic infarction. Am Surg 64:182–188PubMed
36.
go back to reference Antopolsky M, Hiler N, Salameh S, Godstein S, Stalnikowicz R (2009) Splenic infarction: 10 years of experience. Am J Emerg Med 27:262–265CrossRefPubMed Antopolsky M, Hiler N, Salameh S, Godstein S, Stalnikowicz R (2009) Splenic infarction: 10 years of experience. Am J Emerg Med 27:262–265CrossRefPubMed
37.
go back to reference Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and a splenic infarct due to CMV or lymphoma? Heart Lung 46:394–396CrossRefPubMed Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and a splenic infarct due to CMV or lymphoma? Heart Lung 46:394–396CrossRefPubMed
38.
go back to reference Cunha BA, Petelin A (2013) Fever of unknown origin (FUO) due to large B-cell lymphoma: the diagnostic significance of highly elevated alkaline phosphatase and serum ferritin levels. Heart Lung 42:67–71CrossRefPubMed Cunha BA, Petelin A (2013) Fever of unknown origin (FUO) due to large B-cell lymphoma: the diagnostic significance of highly elevated alkaline phosphatase and serum ferritin levels. Heart Lung 42:67–71CrossRefPubMed
39.
go back to reference Iioka F, Honjo G, Misaki T et al (2016) A unique subtype of duffuse large B-cell lymphoma primarily involving the bone marrow, spleen and liver defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography. Leuk Lymphoma 57:2593–2602CrossRefPubMed Iioka F, Honjo G, Misaki T et al (2016) A unique subtype of duffuse large B-cell lymphoma primarily involving the bone marrow, spleen and liver defined by fluorodeoxyglucose-positron emission tomography combined with computed tomography. Leuk Lymphoma 57:2593–2602CrossRefPubMed
40.
go back to reference Cunha BA (2007) Fever of unknown origin: clinical overview of classic and current concepts. Infect Dis Clin N Am 21:867–915CrossRef Cunha BA (2007) Fever of unknown origin: clinical overview of classic and current concepts. Infect Dis Clin N Am 21:867–915CrossRef
Metadata
Title
Lessons learned from splenic infarcts with fever of unknown origin (FUO): culture-negative endocarditis (CNE) or malignancy?
Authors
Burke A. Cunha
Bertamaria Dieguez
Alena Varantsova
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 6/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3200-3

Other articles of this Issue 6/2018

European Journal of Clinical Microbiology & Infectious Diseases 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.